You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華神科技(000790.SZ):三七通舒膠囊中長期增長來源於產品在新治療領域的二次開發,未來將拓展心內科領域用藥
格隆匯 05-11 14:47

格隆匯5月11日丨華神科技(000790.SZ)於2023年5月9日接受特定對象調研,就“主要品種三七通舒膠囊未來主要增長點在哪裏?”,公司回覆稱,三七通舒膠囊中長期增長來源於產品在新治療領域的二次開發,短期關注基藥市場準入,現階段主要開發新的治療領域。因三七通舒膠囊目前主要在神內領域用藥,未來將拓展心內科領域用藥,根據處方藥銷售發展曲線預測冠心病新治療領域三年內將達到一定用量標準。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account